The estimated Net Worth of Robert Eckert is at least $26 Milion dollars as of 18 August 2022. Mr. Eckert owns over 6,600 units of AMGEN stock worth over $6,990,296 and over the last 21 years he sold AMGN stock worth over $18,650,655. In addition, he makes $396,530 as Lead Independent Director at AMGEN.
Robert has made over 24 trades of the AMGEN stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 6,600 units of AMGN stock worth $1,643,400 on 18 August 2022.
The largest trade he's ever made was exercising 887,727 units of AMGEN stock on 29 June 2009 worth over $9,986,929. On average, Robert trades about 29,073 units every 50 days since 2003. As of 18 August 2022 he still owns at least 21,184 units of AMGEN stock.
You can see the complete history of Mr. Eckert stock trades at the bottom of the page.
Robert A. Eckert serves as Lead Independent Director of the Company. Mr. Eckert is our lead independent director. Mr. Eckert has been an Operating Partner at Friedman Fleischer & Lowe, a private equity firm, since 2014. Mr. Eckert was the Chief Executive Officer of Mattel, Inc., a toy design, manufacture and marketing company, having held this position from 2000 through 2011, and its Chairman of the Board from 2000 through 2012. He was President and Chief Executive Officer of Kraft Foods Inc., a consumer packaged food and beverage company, from 1997 to 2000, Group Vice President from 1995 to 1997, President of the Oscar Mayer Foods Division from 1993 to 1995 and held various other senior executive and other positions from 1977 to 1992. Mr. Eckert has been a director of McDonald’s Corporation, a company which franchises and operates McDonald’s restaurants in the global restaurant industry, since 2003, serving as the Chair of the Public Policy and Strategy Committee and a member of the Executive and Governance Committees. Mr. Eckert also has served as a director of Levi Strauss & Co., a jeans and casual wear manufacturer, since 2010, serving as Chair of the Compensation Committee and a member of the Nominating, Governance and Corporate Citizenship Committee. Levi Strauss & Co. was a privately-held company until March 2019 when it became publicly traded. In March 2020, Mr. Eckert was appointed a director of Uber Technologies, Inc., a personal mobility, meal delivery and logistics technology platform, serving on its Compensation and Nominating and Governance Committees. Mr. Eckert was a director of Smart & Final Stores, Inc., a warehouse store, from 2013 until 2014 prior to it becoming a publicly-traded company. He was appointed director of Eyemart Express Holdings LLC, a privately-held eyewear retailer and portfolio company of Friedman Fleischer & Lowe, in 2015. Mr. Eckert is on the Global Advisory Board of the Kellogg School of Management at Northwestern University and serves on the Eller College Nation
As the Lead Independent Director of AMGEN, the total compensation of Robert Eckert at AMGEN is $396,530. There are 9 executives at AMGEN getting paid more, with Robert Bradway having the highest compensation of $19,612,800.
Robert Eckert is 65, he's been the Lead Independent Director of AMGEN since 2016. There are 3 older and 22 younger executives at AMGEN. The oldest executive at AMGEN Inc. is Fred Hassan, 74, who is the Independent Director.
Over the last 22 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer a Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: